# Xi'an Medisotope Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xi-an-medisotope-technology-co

- Industry: Materials
- Headquarters: Xianyang, China
- Website: www.xa-medisotope.com
- Total disclosed funding: $14M
- Latest round: Angel (Dec 11, 2025)
- Investors on record: 2

## About

Based in Shaanxi, China and founded in 2019 by Quanshi Zhang, Xi'an Medisotope Technology Co., Ltd. is a high-tech enterprise engaging in the research, development and production of medical isotopes. The company has established strategic partnerships with institutes such as the China Academy of Engineering Physics, Xi'an Jiaotong University, China Nuclear Power Operation Management Co., Ltd., etc.

In August 2026, Xi'an Medisotope Technology Co., Ltd. raised a Pre-Series A funding from China Reform Holdings.

Xi'an Medisotope Technology Co., Ltd. offers medical isotopes including Actinium-225, Lead-212, Copper-67, Scandium-47 and Molybdenum-99 and other related products which are applied for diagnosing and treating cancer, heart disease, neurological disorders and other diseases.

The company's revenue is generated by providing medical isotope products.

The Pre-Series A round of financing will be mainly used for site construction, equipment purchase, technology research and development, and daily operations.

## Funding rounds

- Angel, Dec 11, 2025, $14M — Casstar Capital, Zing Capital
- Angel, Mar 16, 2025 — Casstar Capital

## Investors

- Casstar Capital (https://capitalatlas.ai/funds/casstar-capital) — Angel
- Zing Capital — Angel